Homepage
PR Newswire
AvePoint will be the first Spore-incorporated company that now has a dual listing on Nasdaq and SGX, with the later listing probably thanks to 65 Equity Partners. It is denominated in SGD and will raise ~300mil from a secondary share sale by the controlling shareholders, and it seems sales are only to institutional investors.
Looking at 65 Equity Partner's existing portfolio, there might be 2-3 more companies that will list on the SGX in the future if it continues to execute its mandate.
65 Equity Partners-backed AvePoint announces dual listing on SGX to continue global expansion
AvePoint, the 65 Equity Partners-backed global data security firm, announced Thursday its listing on the Main Board of the Singapore Exchange Securities Trading Limited (SGX).
Concurrent with the SGX listing, AvePoint completed a successful secondary offering of shares of its common stock, which was more than three times oversubscribed.
Forty institutional investors were ultimately allocated shares in the offering, with strong support from long only investors, which allowed for pricing from the midpoint of the range at S$19.50 ($15.19) per share.
https://technode.global/2025/09/19/65-eq...expansion/
65 Equity Partners' portfolio: https://www.65equitypartners.com/portfolios/
Looking at 65 Equity Partner's existing portfolio, there might be 2-3 more companies that will list on the SGX in the future if it continues to execute its mandate.
65 Equity Partners-backed AvePoint announces dual listing on SGX to continue global expansion
AvePoint, the 65 Equity Partners-backed global data security firm, announced Thursday its listing on the Main Board of the Singapore Exchange Securities Trading Limited (SGX).
Concurrent with the SGX listing, AvePoint completed a successful secondary offering of shares of its common stock, which was more than three times oversubscribed.
Forty institutional investors were ultimately allocated shares in the offering, with strong support from long only investors, which allowed for pricing from the midpoint of the range at S$19.50 ($15.19) per share.
https://technode.global/2025/09/19/65-eq...expansion/
65 Equity Partners' portfolio: https://www.65equitypartners.com/portfolios/
I am not a certified financial advisor and so nothing of what I say should be construed as financial advice. Please consult a certified financial advisor for advice instead.